Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient

被引：8

作者：

Artemiadis, A. K. ^{[1
]}

Nikolaou, G. ^{[2
]}

Kolokythopoulos, D. ^{[3
]}

Tegos, N. ^{[4
]}

Terentiou, A. ^{[2
]}

Triantafyllou, N. ^{[1
]}

Papanastasiou, I. ^{[2
]}

机构：

[1] Univ Athens, Sch Med, Aeginit Hosp, Dept Neurol 1, GR-11521 Athens, Greece

[2] NIMTS Hosp, Dept Neurol, Athens, Greece

[3] NIMTS Hosp, Dept Hematol, Athens, Greece

[4] Minist Hlth, Hellen Ctr Dis Control & Prevent, Athens, Greece

来源：

关键词：

Visceral; leishmaniasis; fingolimod; multiple sclerosis; side-effect; infection;

D O I：

10.1177/1352458514555788

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：795 / 796

页数：2

共 5 条

[1] Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, Jeffrey A.
Barkhof, Frederik
Comi, Giancarlo
Hartung, Hans-Peter
Khatri, Bhupendra O.
Montalban, Xavier
Pelletier, Jean
Capra, Ruggero
Gallo, Paolo
Izquierdo, Guillermo
Tiel-Wilck, Klaus
de Vera, Ana
Jin, James
Stites, Tracy
Wu, Stacy
Aradhye, Shreeram
Kappos, Ludwig
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) : 402 - 415
[2] Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532
[3] FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
Mehling, M.
Brinkmann, V.
Antel, J.
Bar-Or, A.
Goebels, N.
Vedrine, C.
Kristofic, C.
Kuhle, J.
Lindberg, R. L. P.
Kappos, L.
[J]. NEUROLOGY, 2008, 71 (16) : 1261 - 1267
[4] Opata Michael M., 2013, Current Immunology Reviews, V9, P190, DOI 10.2174/1573395509666131126231209
[5] Immunopathogenesis of infection with the visceralizing Leishmania species
Wilson, ME
Jeronimo, SMB
Pearson, RD
[J]. MICROBIAL PATHOGENESIS, 2005, 38 (04) : 147 - 160